Sarah Cavanaugh | Senior Vice President, Corporate Affairs and Administration |
Anthony Marucci | Co-founder, President and Chief Executive Officer |
Tibor Keler | Co-Founder and Chief Scientific Officer |
Diane Young | Senior Vice President and Chief Medical Officer |
Margo Heath-Chiozzi | Senior Vice President of Regulatory Affairs |
Diego Alvarado | Executive Director of Research |
Yatin Suneja | Guggenheim Partners |
Chris Howerton | Jefferies |
Thomas Smith | SVB Leerink |
Sam Slutsky | LifeSci Capital |
Kristen Kluska | Cantor Fitzgerald |
Joe Pantginis | H.C. Wainwright |
Ladies and gentlemen, thank you for standing by, and welcome to the Celldex Therapeutics Year-End 2021 Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference call is being recorded. [Operator Instructions] I would now like to hand the conference over to your speaker today, Sarah Cavanaugh.